News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2024 Caitlin E. Cox December 31, 2024
Presentation TCT 2024 TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series Presenter: Kari Saville October 30, 2024
Presentation TCT 2024 Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie Presenter: Naomi Fisher October 28, 2024
Presentation TCT 2024 Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN Presenter: Lucas Lauder October 28, 2024
Presentation TCT 2024 Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic Presenter: Raven Voora October 28, 2024
Presentation TCT 2024 Alternative Renal Denervation Devices – From Ablative Solutions to Verve Presenter: Michael Weber October 28, 2024
Presentation TCT 2024 Tips and Tricks for Performing a Safe and Effective Renal Denervation (With Video Examples) Presenter: Flavio Ribichini October 28, 2024
Presentation TCT 2024 TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea Presenter: Chang Wook Jeong October 28, 2024
Presentation TCT 2024 Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial Presenter: David Kandzari October 28, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
Presentation Fellows 2024 Renal Denervation for Hypertension: What You Need to Know Presenter: Ajay J. Kirtane April 14, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024